Laurence Hicks - Aug 31, 2023 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTH)

Role: Director
Signature: /s/ Laurence Hicks
Stock symbol: ARTH
Transactions as of: Aug 31, 2023
Transactions value $: $2,830
Form type: 4
Date filed: 9/8/2023, 05:47 PM
Previous filing: Nov 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARTH	Common Stock	Purchase	$2.83K	+10.3K		$0.28^*	10.3K	Aug 31, 2023	Drake Partners	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ARTH	Warrants (right to buy)	Award		+20.6K			20.6K	Aug 31, 2023	Common Stock	20.6K	$1.00	Drake Partners	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person is an owner of Drake Partners. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F2	The warrants are exercisable after the earlier of (A) the six-month anniversary after the date of issuance and (B) the date that a registration statement registering the shares underlying the warrants is declared effective.
F3	The warrants were sold as part of a unit with the shares of common stock reported in Table I, at a price of $0.275 per share of common stock and accompanying warrant to purchase two shares of common stock.